AVEO. New Clinical Data on AVEO Oncology’s Tivozanib and Ficlatuzumab to be Presented at the ESMO 2012 Congress http://finance.yahoo.com/news/clinical-data-aveo-oncology-tivozanib-103000610.html stockcharts.com/c-sc/sc?s=AVEO&p=W&yr=1&mn=0&dy=0&i=t48382739263&r=1348139293702